Ad is loading...
NDGCX
Price
$21.92
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VFINX
Price
$549.92
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

NDGCX vs VFINX

Header iconNDGCX vs VFINX Comparison
Open Charts NDGCX vs VFINXBanner chart's image
Neuberger Berman Dividend Growth C
Price$21.92
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$549.92
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
NDGCX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NDGCX vs. VFINX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NDGCX is a StrongBuy and VFINX is a StrongSell.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.28T vs. NDGCX (104M). VFINX pays higher dividends than NDGCX: VFINX (1.24) vs NDGCX (0.03). NDGCX was incepted earlier than VFINX: NDGCX (9 years) vs VFINX (48 years). NDGCX is a more actively managed with annual turnover of: 18.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than NDGCX: VFINX (0) vs NDGCX (1000). VFINX annual gain was more profitable for investors over the last year : 30.57 vs. NDGCX (19.63). VFINX return over 5 years is better than : 91.24 vs. NDGCX (64.35).
NDGCXVFINXNDGCX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years48 years-
Gain YTD15.12625.01160%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets104M1.28T0%
Annual Yield % from dividends0.031.243%
Returns for 1 year19.6330.5764%
Returns for 3 years9.8227.0736%
Returns for 5 years64.3591.2471%
Returns for 10 yearsN/A189.02-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS8.130.28
+3.57%
iTeos Therapeutics
CNC60.351.25
+2.12%
Centene Corp
SKY100.081.94
+1.98%
Champion Homes Inc
CNNE20.770.23
+1.12%
Cannae Holdings
CLDI2.15-0.14
-6.11%
Calidi Biotherapeutics